(Total Views: 218)
Posted On: 08/10/2021 3:18:09 PM
Post# of 51
NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Participation in Q3 Virtual Investor Summit
Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from sleep-disordered breathing, including mild-to-moderate obstructive sleep apnea (“OSA”), will participate in the upcoming two-day Q3 Virtual Investor Summit. Vivos CEO Kirk Huntsman along with CFO Brad Amman and Ed Loew, Vivos investor relations officer, will be presenting at the event, which will be held Aug. 17–18; their presentation is slated to begin at 9:30 a.m. ET on Aug. 18, 2021. The Vivos presentation will be available online, and a replay of the presentation will be available to view following the conference on the Vivos corporate website.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from sleep-disordered breathing, including mild-to-moderate obstructive sleep apnea (“OSA”), will participate in the upcoming two-day Q3 Virtual Investor Summit. Vivos CEO Kirk Huntsman along with CFO Brad Amman and Ed Loew, Vivos investor relations officer, will be presenting at the event, which will be held Aug. 17–18; their presentation is slated to begin at 9:30 a.m. ET on Aug. 18, 2021. The Vivos presentation will be available online, and a replay of the presentation will be available to view following the conference on the Vivos corporate website.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)
